Third mRNA COVID-19 vaccine dose appears to be safe
Apr 15, 2022
There were higher reports of low-severity adverse effects but no change in severe events.
COVID-19 booster compliance among long-term care workers remains low
By
Kathleen Steele Gaivin
Apr 15, 2022
New Jersey Gov. Phil Murphy (D) this week clarified that long-term care and other healthcare workers in the state satisfy the state’s vaccination requirements once they obtain one booster dose of a COVID-19...
To boost or not to boost: that is the question
By
Kimberly Bonvissuto
Apr 14, 2022
Without federal health and regulatory agencies taking a strong position on a second COVID-19 booster shot, confusion abounds over who should get boosted, and when.
Vaccination offers extra protection after SARS-CoV-2 infection
Apr 06, 2022
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination.
FDA panel meets to craft future vaccine strategy
Apr 06, 2022
No official vote is planned, and no specific vaccine products will be discussed.
Risk for acute MI not increased with two-dose HepB-CpG vaccine
Apr 01, 2022
The noninferiority study shows no increased risk for acute myocardial infarction with the two-dose HepB-CpG vaccine versus the three-dose HepB-alum vaccine.
Booster strategies after Janssen shot increased protection against omicron
Mar 30, 2022
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses.
As second COVID-19 booster dose is approved, senior living calls for help
By
Kimberly Bonvissuto
Mar 30, 2022
As public health officials brace for a potential surge in coronavirus cases due to the BA.2 variant, the federal government on Tuesday approved a second COVID-19 booster dose for higher-risk individuals.
Low COVID-19 vaccination rates among Medicaid beneficiaries cause for concern: senators
By
Kimberly Bonvissuto
Mar 29, 2022
Concern over lagging vaccination rates among Medicaid beneficiaries has prompted two Democratic leaders to request a study from the Government Accountability Office on potential barriers to vaccination.
Risk for myocarditis low after third dose of BNT162b2 vaccine
Mar 24, 2022
The incidence of myocarditis among young men estimated to be 6.43 and 11.25 per 100,000 vaccines in the week to two weeks after third dose..